BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND TG, Thyroglobulin AND Staging
144 results:

  • 1. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
    Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
    Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Ablation Rates and Long-Term Outcome Following Low-Dose Radioiodine for Differentiated thyroid cancer in the West of Scotland: A Retrospective Analysis.
    Graham K; Tough F; Belikova H; Wotherspoon I; Colville D; Reed N
    Endocr Pract; 2024 Apr; 30(4):327-332. PubMed ID: 38184240
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Incidental thyroid Tissue in Sentinel Nodes From Oral Squamous Cell Carcinoma.
    Schilling C; Collins L; Farrow A; McGurk M; Bisase B; Kerawala C; Wan S; Hall G; Thavaraj S
    Laryngoscope; 2024 Mar; 134(3):1278-1281. PubMed ID: 37610258
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Lymphatic Contrast-enhanced US to Improve the Diagnosis of Cervical Lymph Node Metastasis from thyroid cancer.
    Zhang Y; Lu YY; Li W; Zhao JH; Zhang Y; He HY; Li J; Luo YK
    Radiology; 2023 May; 307(4):e221265. PubMed ID: 37014243
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis.
    Patti L; Gay S; Musso L; Maltese C; Spina B; Minuto M; Morbelli S; Vera L; Boschetti M; Ferone D; Albertelli M
    J Endocrinol Invest; 2023 Oct; 46(10):2157-2164. PubMed ID: 36976482
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of staging and recurrence predictors in patients with differentiated thyroid cancer between the 7th and 8th editions of the American Joint Committee on cancer staging systems.
    Elbasan O; Gogas Yavuz D
    Minerva Endocrinol (Torino); 2023 Sep; 48(3):261-273. PubMed ID: 36756784
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evaluation of the role of prophylactic bilateral central neck lymph node dissection in patients with papillary thyroid carcinoma: a case controlled study.
    Shahriarirad R; Meshkati Yazd SM; Zahedi R; Mokhtari Ardekani A; Rekabi MM; Nasiri S
    Updates Surg; 2023 Apr; 75(3):679-689. PubMed ID: 36527603
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical Value of Ultrasonography and Serum Markers in Preoperative N staging of thyroid cancer.
    Wang H; Zhao S; Xu C; Yao J; Yu X; Xu D
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429049
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Chronology of thyroid cancer.
    Miyauchi A
    World J Surg; 2023 Feb; 47(2):288-295. PubMed ID: 36153411
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Assesment of attainment of recommended TSH levels and levothyroxine compliance in differentiated thyroid cancer patients.
    Yavuz DG; Yazan CD; Hekimsoy Z; Aydin K; Gokkaya N; Ersoy C; Akalın A; Topaloglu O; Aydogan BI; Dilekci ENA; Alphan Uc Z; Cansu GB; Ozsari L; Iyidir OT; Olgun ME; Keskin L; Mert M; Can B; Gungor K; Galip T; Cantürk Z; Elbuken G; Pekkolay Z; Kutbay NO; Yorulmaz G; Kalkan AT; Unsal YA; Yay A; Karagun B; Bozkur E
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):833-840. PubMed ID: 35639050
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A Retrospective Cohort Study with Validation of Predictors of Differentiated thyroid cancer Outcomes.
    Wijewardene A; Gill AJ; Gild M; Learoyd DL; Glover AR; Sywak M; Sidhu S; Roach P; Schembri G; Hoang J; Robinson B; Tacon L; Clifton-Bligh R
    Thyroid; 2022 Oct; 32(10):1201-1210. PubMed ID: 35620896
    [No Abstract]    [Full Text] [Related]  

  • 12. The Relationship Between Primary thyroid Lymphoma and Various Types of thyroid Autoimmunity: A Retrospective Cohort Study of 498 Cases, Including 9 Cases with Graves' Disease.
    Suzuki N; Watanabe N; Noh JY; Yoshimura R; Mikura K; Kinoshita A; Suzuki A; Mitsumatsu T; Fukushita M; Matsumoto M; Yoshihara A; Katoh R; Sugino K; Ito K
    Thyroid; 2022 May; 32(5):552-559. PubMed ID: 35229626
    [No Abstract]    [Full Text] [Related]  

  • 13. Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single-center observational study in Taiwan.
    Sun JH; Li YR; Chang KH; Liou MJ; Lin SF; Tsai SS; Yu MC; Hsueh C; Chen ST
    Biomed J; 2022 Dec; 45(6):923-930. PubMed ID: 34808423
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical significance of extra-thyroid
    Long B; Yao LF; Chen SC; Shui J; Ye XM; Yi HQ; Lou C
    J Int Med Res; 2021 May; 49(5):3000605211012667. PubMed ID: 34024177
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Prediction and investigation of the potential risk factors for the upper mediastinal metastasis of papillary thyroid carcinoma].
    Liu Y; Xu SY; Liu K; Wang XL; Liu SY; Xu ZG; Liu J
    Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):477-483. PubMed ID: 33902211
    [No Abstract]    [Full Text] [Related]  

  • 16. Diagnostic Value of Exosomal miR-148a-3p in the Serum of Patients with Differentiated thyroid cancer.
    Li S; Zhang S; Yang W; Li F; Long H
    Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616326
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A retrospective study of the risk factors and the prognosis in patients with papillary thyroid carcinoma depending on the number of lymph node metastasis.
    Rui ZY; Liu Y; Zheng W; Wang X; Meng ZW; Tan J; Li N; Jia Q
    Clin Exp Med; 2021 May; 21(2):277-286. PubMed ID: 33386568
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [ANAPLASTIC TRANSFORMATION OF METASTATIC PAPILLARY thyroid CARCINOMA IN A CERVICAL LYMPH NODE - A TIMELINE].
    Horev Y; Vaknine H; Cinamon U
    Harefuah; 2020 Nov; 159(11):809-814. PubMed ID: 33210851
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prophylactic central node dissection in differentiated thyroid cancer: A prospective tertiary care center experience.
    Mukherjee APASADD; Arnav SRDA; Agarwal SRDVK; Sharma APASADR; Saidha APASADN
    Cancer Treat Res Commun; 2020; 25():100228. PubMed ID: 33130431
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. How to better stratify the risk of differentiated thyroid carcinomas: the key role of radioactive iodine therapy, age, and gender.
    Piccardo A; Siri G; Raffa S; Castellana M; Foppiani L; Bottoni G; Ugolini M; Cistaro A; Catrambone U; Altrinetti V; Massollo M; Arlandini A; Giovanella L; Cabria M; Trimboli P
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):822-830. PubMed ID: 32955602
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.